Related Experiment Video
Updated: Jun 25, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Evaluating targeted COVID-19 vaccination strategies with agent-based modeling
Thomas J Hladish1,2, Alexander N Pillai1, Carl A B Pearson3,4
1Department of Biology, University of Florida, Gainesville, Florida, United States of America.
Targeting high-risk individuals for COVID-19 vaccination is most effective for reducing severe outcomes. Age-based targeting also outperforms mass vaccination and ring vaccination strategies.
Area of Science:
- Epidemiology
- Public Health
- Computational Modeling
Background:
- COVID-19 vaccine distribution strategies significantly impact public health outcomes.
- Understanding the comparative effectiveness of different distribution approaches is crucial for pandemic response.
Purpose of the Study:
- To evaluate and compare the effectiveness of various COVID-19 vaccine distribution strategies.
- To identify optimal strategies for reducing severe outcomes like hospitalizations and deaths.
Main Methods:
- Utilized an agent-based model of human activity and COVID-19 transmission.
- Calibrated the model using detailed epidemiological data from Florida, USA (cases, hospitalizations, deaths, seroprevalence, breakthrough infections).
- Simulated four distribution strategies under varying vaccine supply levels from late 2020 to early 2022.
Main Results:
- Targeting individuals at high risk of severe disease emerged as the most effective strategy for reducing severe outcomes across all scenarios.
- Ring vaccination, while effective for infection reduction, was least effective for preventing deaths.
- Using age group as a proxy for disease risk also outperformed mass vaccination and ring vaccination.
Conclusions:
- Active targeting of high-risk populations is the optimal COVID-19 vaccine distribution strategy for minimizing severe outcomes.
- The relative benefit of targeting strategies varies with vaccine availability and specific viral waves (Alpha, Delta, Omicron).
- Despite variations in absolute benefit, the ranking of strategy performance in preventing severe outcomes remained consistent across different vaccine supply levels.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Vaccinations
Steps in Outbreak Investigation
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

